Analyst Activity – Piper Jaffray Companies Reiterates Hold on Insys Therapeutics (NASDAQ:INSY)

ME Staff
-
0

Analyst Ratings For Insys Therapeutics (NASDAQ:INSY)

Today, Piper Jaffray Companies reiterated its Hold rating on Insys Therapeutics (NASDAQ:INSY) with a price target of $10.00.

There are 2 hold ratings, 2 buy ratings on the stock.

The current consensus rating on Insys Therapeutics (NASDAQ:INSY) is Buy (Score: 2.50) with a consensus target price of $13.33 per share, a potential 12.33% upside.

Some recent analyst ratings include

  • 7/26/2017-Piper Jaffray Companies Reiterated Rating of Hold.
  • 7/4/2017-Oppenheimer Holdings, Inc. Reiterated Rating of Hold.
  • 6/9/2017-Jefferies Group LLC Reiterated Rating of Buy.
  • 4/14/2016-Janney Montgomery Scott initiated coverage with a Buy rating.

Recent Insider Trading Activity For Insys Therapeutics (NASDAQ:INSY)
Insys Therapeutics (NASDAQ:INSY) has insider ownership of 67.90% and institutional ownership of 28.18%.

  • On 6/14/2017 Saeed Motahari, CEO, bought 5,400 with an average share price of $11.10 per share and the total transaction amounting to $59,940.00. View SEC Filing
  • On 6/1/2017 Rohit Vishnoi, Director, bought 4,000 with an average share price of $14.14 per share and the total transaction amounting to $56,560.00. View SEC Filing
  • On 5/18/2017 Steven J Meyer, Director, bought 8,000 with an average share price of $12.21 per share and the total transaction amounting to $97,680.00. View SEC Filing
  • On 5/16/2017 Saeed Motahari, CEO, bought 4,500 with an average share price of $11.98 per share and the total transaction amounting to $53,910.00. View SEC Filing
  • On 11/4/2016 Steven J Meyer, Director, bought 10,000 with an average share price of $10.75 per share and the total transaction amounting to $107,500.00. View SEC Filing
  • On 8/16/2016 Theodore H Stanley, Director, sold 15,000 with an average share price of $18.02 per share and the total transaction amounting to $270,300.00. View SEC Filing
  • On 8/12/2016 John N Kapoor Trust Dated Sept, Major Shareholder, bought 5,700 with an average share price of $18.57 per share and the total transaction amounting to $105,849.00. View SEC Filing

Recent Trading Activity for Insys Therapeutics (NASDAQ:INSY)
Shares of Insys Therapeutics closed the previous trading session at 11.87 down -0.32 -2.63% with 699,288 shares trading hands.